Typicality: | 0.207 |
Saliency: | 0.105 |
with abatacept | 2 | other |
in abatacept plus methotrexate group | 2 | location |
improvement → be observed at → 12 months | 3 |
improvement → be seen at → 12 and 24 months | 3 |
negative | neutral | positive |
0.002 | 0.227 | 0.771 |
Raw frequency | 6 |
Normalized frequency | 0.105 |
Modifier score | 0.500 |
Perplexity | 66.352 |